$88.94-1.19 (-1.32%)
KKR & Co.
KKR & Co. Inc. in the Financial Services sector is trading at $88.94 with a market capitalization of $84.4B. Wall Street consensus targets $125.53 (19 analysts), implying a +41.1% move over the next 12 months. The stock is currently near its 52-week low of $82.67, remaining 20.0% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.25B↓ | $5.69B↑ | $5.46B↑ | $5.00B↑ | $3.05B |
| Gross Profit | $1.18B↑ | $1.14B↓ | $1.35B↑ | $1.05B↑ | -$84.67M |
| Operating Income | $456.47M↑ | $356.90M↓ | $512.72M↑ | $327.26M↑ | -$706.69M |
| Net Income | $405.23M↓ | $1.15B↑ | $900.36M↑ | $510.12M↑ | -$185.92M |
KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine...
KKR recently entered advanced talks to acquire Sweden-based Medicover’s 66.9% stake in its Indian hospital business for at least US$1.05 billion, while also reporting quarter-to-date monetization income above US$900 million, mostly from realized performance fees. Alongside these moves, KKR is aligning its reporting of realized performance fees with industry practice, a shift that may help investors better assess the quality and sustainability of its earnings. We’ll now examine how KKR’s...
KKR is reported to be in advanced talks to acquire a majority stake in Medicover Hospitals India. The potential deal could be valued at more than $1b and would expand KKR's healthcare platform in India. If completed, the transaction would add a large Indian hospital network to KKR's global private equity portfolio. Investors watching KKR (NYSE:KKR) are seeing the company explore a sizeable healthcare transaction in India at a time when its stock trades around $90.13. Over the past year, the...
Financial stocks were higher in Friday afternoon trading, with the NYSE Financial Index increasing 0
If you are wondering whether KKR at around US$92.65 is starting to look attractively priced or still demanding, the starting point is to understand what the current market value actually reflects. The stock has fallen about 4.5% over the past week and is down 2.5% over the past month, which sits against a much steeper year to date decline of 28.1% and a 29.3% decline over the past year, even though the 3 year and 5 year returns of 69.1% and 61.8% tell a very different story. Recent headlines...
KKR Asset Management (NYSE:KKR) shares added more than 3% on Thursday after the alternative asset manager provided an update highlighting stronger monetization activity and changes to its financial reporting. The firm announced that monetization activity exceeded $900 million for the period...